Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of August 2023, specifically reporting a transaction notification dated August 9, 2023. The document serves as a regulatory disclosure of a securities transaction involving a Person Discharging Managerial Responsibilities (PDMR) rather than a periodic financial report.
Key Financial Metrics
The filing does not provide company-wide financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data present relates to a specific share transaction:
- Instrument: Ordinary Shares of 31 pence each (ISIN: GB00BN7SWP63).
- Transaction Type: Sale.
- Volume: 24,292 shares.
- Price: £13.6891 per share.
- Total Value: Approximately £332,500 (calculated from volume and price).
Material Changes
There are no material changes to the company's financial position or operations reported in this filing. The document solely discloses a reduction in the shareholding of a specific executive.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory notification of a transaction executed on the London Stock Exchange (XLON) on August 8, 2023.
Investor Verification Points
- Verify the identity of the seller: Regis Simard, President, Global Supply Chain.
- Confirm the transaction date (August 8, 2023) and execution venue (London Stock Exchange).
- Note that this filing does not reflect the company's overall financial performance for the period.